Can continuous glucose monitors benefit people without diabetes? - Breakthrough T1D

Continuous glucose monitors, or CGMs, have become increasingly popular with people who do not live with type 1 diabetes (T1D) as a way to observe the impact of activity and food on their blood-glucose levels. While increased visibility of T1D technology can help normalize an advanced way to manage what is often an invisible condition, can wearing a CGM benefit people without T1D? Breakthrough T1D takes a look. Continuous glucose monitors are small, wearable devices that continuously measure a person’s blood-glucose levels. They are primarily used in place of glucose meters and finger pokes. A sensor just under the skin measures the glucose levels in real time. The levels are then relayed to a receiver, smartphone, watch, or insulin pump, which displays the readings. Learn more about CGMs. Continuous glucose monitors have been transformative for daily type 1 diabetes management. They have proven to: Breakthrough T1D has played a pivotal role in the development and accessibility of CGMs

Continuous glucose monitors, or CGMs, have become increasingly popular with people who do not live with type 1 diabetes (T1D) as a way to observe the impact of activity and food on their blood-glucose levels. While increased visibility of T1D technology can help normalize an advanced way to manage what is often an invisible condition , can wearing a CGM benefit people without T1D? Breakthrough T1D takes a look. What are continuous glucose monitors? Continuous glucose monitors are small, wearable devices that continuously measure a person’s blood-glucose levels. They are primarily used in place

related reading

• Is blood sugar monitoring without diabetes worthwhile? - Harvard Healthhealth.harvard.edu
• An LSTM-based Approach Towards Automated Meal Detection from Continuous Glucose Monitoring in Type 1 Diabetes Mellitus | IEEE Conference Publication | IEEE Xploreieeexplore.ieee.org
• Gap Mapgap-map.org
• Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes - PubMedpubmed.ncbi.nlm.nih.gov
• Does Glycemic Variability Impact Mood and Quality of Life? - PMCncbi.nlm.nih.gov
• Checking your browser - reCAPTCHAncbi.nlm.nih.gov
• Biolinq Shine™ Granted De Novo Classification by U.S. FDAglobenewswire.com
• Remote patient monitoring for management of diabetes mellitus in pregnancy is associated with improved maternal and neonatal outcomes - PubMedpubmed.ncbi.nlm.nih.gov
• The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes - PMCncbi.nlm.nih.gov
• If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?derekthompson.org
• A Potential Dramatic Change in Treating Type 1 Diabetes - Jacobs School of Medicine and Biomedical Sciences - University at Buffalomedicine.buffalo.edu
• Oxford University Press | Online Resource Centre | Multiple choice questionsglobal.oup.com